Amanta Healthcare Ltd - 544502 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Amanta Healthcare confirmed the audio recording of its Q4 FY26 Earnings Conference Call is now available on the company website. This provides investors access to the detailed discussions from the call held earlier.
May 19 2026 17:05:00
Amanta Healthcare Ltd - 544502 - Revision In Remuneration Of Managing Director - Recommended By Board Of Directors
Amanta Healthcare's Board of Directors has approved a revised monthly remuneration of Rs.13.29 lakh for Chairman & Managing Director Shri Bhavesh Patel. This revision from Rs.10 lakh is effective April 1, 2026, and requires shareholder approval via Special Resolution at the upcoming Annual General Meeting.
May 19 2026 15:05:00
Amanta Healthcare Limited
Amanta Healthcare's Board of Directors approved a revision in remuneration for Chairman & Managing Director Shri Bhavesh Patel from Rs.10 lakh to Rs.13.29 lakh per month, effective April 1, 2026. This is subject to shareholder approval.
May 19 2026 15:05:00
Amanta Healthcare Ltd - 544502 - Investor Presentation
Amanta Healthcare's Investor Presentation highlights strong FY26 performance with PAT up 36% YoY to Rs.15 Cr. The company significantly reduced its debt-to-equity ratio by over 70% to 1.06x since FY23. Additionally, a new 10.8 MW solar plant will be commissioned in Q1 FY27, expected to generate Rs.9 Cr in annual savings.
May 19 2026 15:05:00
Amanta Healthcare Ltd - 544502 - Amendment To The Code
Amanta Healthcare's board approved the Q4 and full-year financial results for FY26. The full year saw revenue of Rs.287.68 crores and net profit of Rs.14.88 crores, with auditors providing an unmodified opinion.
May 19 2026 15:05:00
Amanta Healthcare Ltd - 544502 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Amanta Healthcare filed its Q4 FY26 IPO proceeds utilization report. The company spent Rs.47.66 crore on the SteriPort manufacturing line, but the project faces delays due to supplier issues, impacting its operational timeline.
May 15 2026 17:05:00
Amanta Healthcare Ltd - 544502 - Board Meeting Intimation for To Consider And Approve The Financial Results For The Period Ended March 31, 2026
Amanta Healthcare's board is scheduled to meet on May 19, 2026, to consider and approve the audited financial results for the quarter and financial year ended March 31, 2026. This meeting is crucial as it will provide an overview of the company's financial performance.
May 11 2026 16:05:00
Amanta Healthcare Ltd - 544502 - Clarification Letter On Earlier Disclosure Submitted On April 18Th, 2026, Pursuant To SEBI (PIT) Regulations, 2015
Amanta Healthcare's promoter Shri Bhavesh Patel clarified the acquisition of 15,500 equity shares. This transaction increased his total holding to 6,326,544 shares, representing 16.29% of the total voting capital.
Apr 22 2026 17:04:00
Amanta Healthcare Limited
Amanta Healthcare Limited clarified that 15,500 shares purchased by Promoter Shri Bhavesh Patel on March 30, 2026, were credited to his demat account on April 17, 2026. This revised his total holding from 16.25% to 16.29% of the total voting capital.
Apr 22 2026 17:04:00
Read More